|
ES2245778T3
(es)
*
|
1993-08-11 |
2006-01-16 |
Jenner Technologies |
Vacuna contra el cancer de prostata.
|
|
US20010036928A1
(en)
*
|
1996-04-22 |
2001-11-01 |
Chamberlain Ronald S. |
Heterologous boosting immunizations
|
|
US6969609B1
(en)
|
1998-12-09 |
2005-11-29 |
The United States Of America As Represented By The Department Of Health And Human Serivces |
Recombinant vector expressing multiple costimulatory molecules and uses thereof
|
|
US7148035B1
(en)
|
1998-11-18 |
2006-12-12 |
Oxford Biomedica (Uk) Limited |
Polypeptide
|
|
EP1036091B2
(en)
*
|
1998-11-18 |
2008-03-26 |
Oxford Biomedica (UK) Limited |
5t4 tumour-associated antigen for use in tumour immunotherapy
|
|
EP1865065A1
(en)
*
|
1998-12-09 |
2007-12-12 |
The Government of the United States of America, as represented by the Secretary, Department of Health and Human Services |
A recombinant vector expressing multiple costimulatory molecules and uses thereof
|
|
DK1137792T3
(da)
*
|
1998-12-09 |
2007-09-10 |
Us Gov Health & Human Serv |
En rekombinant vektor, der udtrykker adskillige costimulatoriske molekyler, og anvendelser deraf
|
|
ES2290449T3
(es)
*
|
2002-04-09 |
2008-02-16 |
Sanofi Pasteur Limited |
Acido nucleico de cea modificado y vectores de expresion.
|
|
US20070196346A1
(en)
*
|
2003-08-21 |
2007-08-23 |
Brown Michael P |
Poxvirus Vector Encoding Prostate Specific Antigens For Treatment Of Prostate Cancer
|
|
CA2550583C
(en)
*
|
2003-10-08 |
2013-01-15 |
Sanofi Pasteur, Inc. |
Modified cea /b7 vector
|
|
WO2005046622A2
(en)
|
2003-11-12 |
2005-05-26 |
Therion Biologics Corporation |
Custom vectors for treating and preventing pancreatic cancer
|
|
DK1694364T3
(da)
*
|
2003-11-12 |
2014-07-21 |
Us Government |
System til behandling og forebyggelse af brystcancer
|
|
EP2387414A1
(en)
|
2009-01-13 |
2011-11-23 |
Transgene SA |
Use of a saccharomyces cerevisiae mitochondrial nucleic acids fraction for immune stimulation
|
|
AU2010206195B2
(en)
|
2009-01-20 |
2016-03-10 |
Transgene Sa |
Soluble ICAM-1 as biomarker for prediction of therapeutic response
|
|
ES2555858T3
(es)
|
2009-03-24 |
2016-01-11 |
Transgene Sa |
Biomarcador para el control de pacientes
|
|
PL2419728T3
(pl)
|
2009-04-17 |
2014-05-30 |
Transgene Sa |
Biomarker do monitorowania pacjentów
|
|
CN102483405B
(zh)
|
2009-07-10 |
2015-12-02 |
特朗斯吉有限公司 |
用于选择患者的生物标志物及相关方法
|
|
WO2012019125A2
(en)
|
2010-08-06 |
2012-02-09 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Biomarkers for prostate cancer and methods for their detection
|
|
US9725494B2
(en)
*
|
2013-05-17 |
2017-08-08 |
United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Soluble CD27 (sCD27) and the use thereof
|
|
AU2014347004B2
(en)
*
|
2013-11-05 |
2019-08-08 |
Bavarian Nordic A/S |
Combination therapy for treating cancer with a poxvirus expressing a tumor antigen and an antagonist and/or agonist of an immune checkpoint inhibitor
|
|
ES2851451T3
(es)
|
2014-05-13 |
2021-09-07 |
Bavarian Nordic As |
Terapia de combinación para tratar cáncer con un poxvirus que expresa un antígeno de tumor y un anticuerpo monoclonal contra TIM-3
|
|
ES2833425T3
(es)
|
2014-07-16 |
2021-06-15 |
Roussy Inst Gustave |
Combinación de virus oncolítico con moduladores de punto de control inmunitario
|
|
EP4523756A3
(en)
|
2015-02-13 |
2025-05-28 |
Transgene |
Immunotherapeutic vaccine and antibody combination therapy
|
|
ES2901468T3
(es)
|
2015-07-31 |
2022-03-22 |
Bavarian Nordic As |
Promotores para mejorar la expresión en poxvirus
|
|
US20190183870A1
(en)
|
2016-01-05 |
2019-06-20 |
The United States Of America, As Represented By The Secretary, Dept. Of Health And Human Services |
Combination of histone deacetylase inhibitor and immunotherapy
|
|
JP6902040B2
(ja)
|
2016-01-28 |
2021-07-14 |
アンスティチュ ナショナル ドゥ ラ サンテ エ ドゥ ラ ルシェルシュ メディカル |
免疫チェックポイント阻害剤の効力を増強する方法
|
|
WO2017136342A1
(en)
|
2016-02-02 |
2017-08-10 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Fulvestrant for inducing immune-mediated cytotoxic lysis of cancer cells
|
|
CA3023022A1
(en)
|
2016-05-04 |
2017-11-09 |
Transgene Sa |
Combination therapy with cpg tlr9 ligand
|
|
CN110198733B
(zh)
|
2016-09-28 |
2024-04-30 |
巴法里安诺迪克有限公司 |
用于增强痘病毒中转基因的稳定性的组合物和方法
|
|
WO2018069316A2
(en)
|
2016-10-10 |
2018-04-19 |
Transgene Sa |
Immunotherapeutic product and mdsc modulator combination therapy
|
|
WO2018091680A1
(en)
|
2016-11-18 |
2018-05-24 |
Transgene Sa |
Cowpox-based oncolytic vectors
|
|
CN110168092A
(zh)
|
2016-12-28 |
2019-08-23 |
特朗斯吉有限公司 |
溶瘤病毒和治疗分子
|
|
MX2019012295A
(es)
|
2017-04-14 |
2020-02-07 |
Tollnine Inc |
Polinucleotidos inmunomoduladores, conjugados de anticuerpos de los mismos y metodos para su uso.
|
|
CA3062549A1
(en)
|
2017-05-15 |
2018-11-22 |
Janssen Vaccines & Prevention B.V. |
Stable virus-containing composition
|
|
EP3624851A1
(en)
|
2017-05-15 |
2020-03-25 |
Janssen Vaccines & Prevention B.V. |
Stable virus-containing composition
|
|
WO2019020543A1
(en)
|
2017-07-28 |
2019-01-31 |
Transgene Sa |
ONCOLYTIC VIRUSES EXPRESSING AGENTS TARGETING METABOLIC IMMUNE MODULATORS
|
|
CN111050790B
(zh)
|
2017-08-24 |
2024-07-12 |
巴法里安诺迪克有限公司 |
通过静脉内施用重组mva和抗体治疗癌症的组合疗法
|
|
CA3093093A1
(en)
|
2018-03-07 |
2019-09-12 |
Transgene |
Parapoxvirus vectors
|
|
WO2020011754A1
(en)
|
2018-07-09 |
2020-01-16 |
Transgene |
Chimeric vaccinia viruses
|
|
AU2019336940B2
(en)
|
2018-09-06 |
2025-09-11 |
Bavarian Nordic A/S |
Storage improved poxvirus compositions
|
|
EP3976071A1
(en)
|
2019-05-29 |
2022-04-06 |
Université de Tours |
Toxoplasma platform for treating cancer
|
|
CA3169523A1
(en)
|
2020-02-28 |
2021-09-02 |
Jaume Pons |
Transglutaminase-mediated conjugation
|
|
JP7712284B2
(ja)
|
2020-03-12 |
2025-07-23 |
バヴァリアン・ノルディック・アクティーゼルスカブ |
ポックスウイルスの安定性を改善する組成物
|
|
US20260049291A1
(en)
|
2022-08-18 |
2026-02-19 |
Transgene |
Chimeric poxviruses
|
|
WO2026041811A1
(en)
|
2024-08-23 |
2026-02-26 |
Transgene |
Recombinant poxvirus and method for regulating the expression of toxic conditional gene products of said recombinant poxvirus in a producing cell
|